-
MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems of any manufacturer
Apr 28, 2020, 11:19 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Apr 28, 2020 - A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturerFull story -
Alfa Chemistry Integrates Its Supply of Boronic Compounds for the Science Community
Apr 28, 2020, 06:11 AM by Michael CroftRONKONKOMA, NY, UNITED STATES - Apr 23, 2020 - The world's leading chemical supplier Alfa Chemistry announced to have integrated its supply of boronic compound products to its customers worldwide, which include borate, boro-amino acids, boronic acids, boronic esters as well as othersFull story -
AI & Medicine Releases Solutions for ADMET Prediction for Pharmaceutical Industry
Apr 28, 2020, 06:01 AM by Michael CroftNY, NY, UNITED STATES - Apr 28, 2020 - AI & Medicine, a company that provides a unique artificial intelligence (AI) drug research and development platform, announced that it offers solutions and expertise on ADMET prediction for pharmaceutical enterprises and medical institutions across the globeFull story -
Visbion Image Cubes deployed at NHS Nightingale Hospitals across the UK
Apr 28, 2020, 05:51 AM by Michael CroftCHERTSEY, SURREY, UK - Apr 28, 2020 - As part of the NHS emergency response to Covid-19, Visbions Image Cube has been deployed at the new NHS Nightingale Hospitals in London, Birmingham and HarrogateFull story -
BOC Sciences Provides Raw Materials for COVID-19 Test Kits
Apr 28, 2020, 02:19 AM by Michael CroftSHIRLEY, NY - Apr 28, 2020 - On April 27, 2020, BOC Sciences, a well-known pharmaceutical raw material supplier, announced its commitment to provide customers with the raw materials needed for the manufacture of COVID-19 test kits to meet the challenges facing the global pharmaceutical industryFull story -
Tjoapack receives investment from Ampersand Capital Partners
Apr 27, 2020, 09:43 AM by Michael CroftETTEN-LEUR, NETHERLANDS - Apr 27, 2020 - Tjoapack Netherlands B.V., a global contract packaging organisation (CPO) for the pharmaceutical industry, today announced a majority investment from Ampersand Capital Partners, a private equity firm that specialises in partnering with entrepreneur-led healthcare companiesFull story -
AI Tools Will Help Us Make the Most of Spatial Biology
Apr 27, 2020, 08:35 AM by Michael CroftFull storyBio-IT World Contributed Commentary | We have heard a lot about cellular and tissue spatial biology lately, and for good reason.
-
Creative Biolabs Releases One-stop HLA Typing and KIR Typing Services
Apr 27, 2020, 02:22 AM by Michael CroftNEW YORK, NY, UNITED STATES - Apr 27, 2020 - The chimeric antigen receptor T (CAR-T) cell immunotherapy covers a wide range of diseases, including acute leukemia, non-Hodgkin's lymphoma, and even tumors, autoimmune diseases, HIV, heart disease, etcFull story -
MIT, Oak Ridge National Laboratory Join In Consorted Efforts To Address COVID-19
Apr 24, 2020, 08:45 AM by Michael CroftFull storyBio-IT World | As COVID-19 continues impacting individuals and communities on a global scale, the bio-IT community is working around the clock to provide both relief and solutions. Their latest efforts include a COVID-19 Research Database, specialized proteins to combat immune overreaction to the virus, promising animal models, and much more.
-
Companies Launch New Framework to Accelerate COVID-19 Research; Streamlines Path for Diagnostics, Monitoring and Clinical Trials
Apr 23, 2020, 10:44 AM by Michael CroftPALO ALTO, CA, UNITED STATES - Apr 23, 2020 - Companies Launch New Framework to Accelerate COVID-19 Research; Streamlines Path for Diagnostics, Monitoring and Clinical TrialsMedable IncFull story -
Data Sharing During A Pandemic: EMBL-EBI’s COVID-19 Portal, GA4GH Take On Data Sharing
Apr 23, 2020, 09:50 AM by Michael CroftBio-IT World EMBL’s European Bioinformatics Institute (EMBL-EBI) has launched its COVID-19 Data Portal, which includes a wide range of data types including genomic, protein, and microscopy data, as well as scientific literature. The new data portal and others like it re-emphasize the importance of data sharing.Full story -
Imvax Appoints Mark Exley, Ph.D. as Chief Scientific Officer
Apr 23, 2020, 08:25 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Apr 23, 2020 - Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO)Full story -
TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief
Apr 22, 2020, 11:50 AM by Michael CroftNORTH READING, MA, UNITED STATES - Apr 22, 2020 - NORTH READING, MASS. (April 16, 2020) -TraceLink Inc., the leading digital platform company for the life sciences industry, today announced a new package of agile solutions designed to digitalize the pharmaceutical supply chainFull story -
AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases
Apr 22, 2020, 10:24 AM by Michael CroftRESEARCH TRIANGLE PARK, NC, US - Apr 22, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that it has acquired BrainVectis, a Paris-based gene therapy company and French National Institute for Health and Medical Research (INSERM) spin-out with expertise and an intellectual property estate for the treatment of neurodegenerative disordersFull story -
Pharma Companies Poised To Go Digital, Starting With Field Reps
Apr 22, 2020, 08:05 AM by Michael CroftFull storyBio-IT World | It often takes a tragedy to trigger change and for pharma companies that tend to be digitally averse, the catalyst may well be the COVID-19 pandemic.
-
Creative Biolabs Released Modotuximab for Research Use
Apr 22, 2020, 01:55 AM by Michael CroftSHIRLEY, NY - Apr 22, 2020 - April 22, 2020, Creative Biolabs, as a leading supplier in recombinant antibody discovery and manufacturing, is equipped with cutting-edge hybridoma development and phage display platforms to be able to offer customers with high-quality and professional servicesFull story -
InSysBio innovates its Immune Response Template Database
Apr 21, 2020, 06:40 AM by Michael CroftMOSCOW, RUSSIA - Apr 15, 2020 - InSysBio is one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling has published the new version of IRT database, one of its core productsFull story -
Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites
Apr 20, 2020, 17:27 PM by Michael CroftPRESTON, UNITED KINGDOM - Apr 20, 2020 -Full story- Panthera's second clinical trial site in the UK, in North Manchester is open for business.
- As a standalone site ideal for existing or new trials with much lower contamination risk during COVID-19
-
Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development
Apr 20, 2020, 10:07 AM by Michael CroftBOURNEMOUTH, UK - Apr 20, 2020 - Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS single cell cloning instrumentFull story -
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
Apr 20, 2020, 06:02 AM by Michael CroftLONDON, UNITED KINGDOM - Apr 20, 2020 - MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge AngelsFull story